CervoMed CRVO
NASDAQ CRVO
$2.94 +0.06 (+2.07%)
As of: Sep 30, 2026 · 9:52 AM EDT

CervoMed (CRVO) Gross Margin (2011 - 2013)

Updated

CervoMed's Gross Margin was 100.00% in Q2 2013, up 0.59 percentage points from 99.41% a year earlier.

Analysis

CervoMed (CRVO) Gross Margin (2011 - 2013) Analysis & Trends

For FY2012, Gross Margin at CervoMed came in at 37.04%, up 341.72 percentage points from FY2011.

  • In earlier years, Gross Margin was -304.68% in FY2011 (+118.83 pp) and -423.51% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 CervoMed 27.35 Mn 27.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 100.00%
Sep 30, 2012 99.41%
Jun 30, 2012 99.41%
Mar 31, 2012 -43.22%
Dec 31, 2011 -541.57%
Sep 30, 2011 -1.44%
API Access

CervoMed Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY